The original thesis for holding INTC remains intact. Price is testing a critical support zone at $89.59-$89.90, which aligns with the high-probability mean-reversion entry identified at trade inception. The 4h MACD histogram is rising, and RSI is improving, signaling strengthening momentum. The reported Intel-SK Hynix HBM4E supply talks provide a fresh fundamental catalyst, reinforcing Intel's strategic position in AI and semiconductors and supporting the case for a rebound toward the $92.77-$95.35 resistance band.
The core mean-reversion thesis remains intact: price is only -0.5% from entry, well above the $86.60 stop, with 4h MACD histogram still positive/rising and RSI rising — the bullish-repair signals that anchored the entry. A fresh positive HBM4E supply catalyst and XLK sector confirmation (now echoing INTC's move rather than confirming downside) support the path back toward $92.77-$95.35 over the remaining horizon.
The original mean-reversion bounce thesis from the $89.59-$89.90 support zone remains intact. Price at $89.48 is only -0.5% from entry with the $86.60 stop providing 3.2% downside buffer, while the $95.20 target offers 6.4% upside — a favorable 2:1 risk/reward. The fresh HBM4E supply talks with SK Hynix provide a positive fundamental catalyst that was absent at entry, reinforcing Intel's AI/foundry recovery narrative and supporting the path back toward the $92.77-$95.35 resistance band.
No model argued for EXIT.
The core mean-reversion thesis remains intact: price is only -0.5% from entry, well above the $86.60 stop, with 4h MACD histogram still positive/rising and RSI rising — the bullish-repair signals that anchored the entry. A fresh positive HBM4E supply catalyst and XLK sector confirmation (now echoing INTC's move rather than confirming downside) support the path back toward $92.77-$95.35 over the remaining horizon.
The core mean-reversion thesis remains intact: price is only -0.5% from entry, well above the $86.60 stop, with 4h MACD histogram still positive/rising and RSI rising — the bullish-repair signals that anchored the entry. A fresh positive HBM4E supply catalyst and XLK sector confirmation (now echoing INTC's move rather than confirming downside) support the path back toward $92.77-$95.35 over the remaining horizon.
▼ Click to expandThe regime flipped from calm/bullish to No Edge/bearish, price is stalled directly under $89.59-$89.90 resistance rather than resuming, and momentum sits below all major SMAs with negative 1day MACD. If price fails at overhead and the dilution overhang reasserts, a break of $85.4 support toward the stop would invalidate the bounce.
▼ Click to expandThe original mean-reversion bounce thesis from the $89.59-$89.90 support zone remains intact. Price at $89.48 is only -0.5% from entry with the $86.60 stop providing 3.2% downside buffer, while the $95.20 target offers 6.4% upside — a favorable 2:1 risk/reward. The fresh HBM4E supply talks with SK Hynix provide a positive fundamental catalyst that was absent at entry, reinforcing Intel's AI/foundry recovery narrative and supporting the path back toward the $92.77-$95.35 resistance band.
The original mean-reversion bounce thesis from the $89.59-$89.90 support zone remains intact. Price at $89.48 is only -0.5% from entry with the $86.60 stop providing 3.2% downside buffer, while the $95.20 target offers 6.4% upside — a favorable 2:1 risk/reward. The fresh HBM4E supply talks with SK Hynix provide a positive fundamental catalyst that was absent at entry, reinforcing Intel's AI/foundry recovery narrative and supporting the path back toward the $92.77-$95.35 resistance band.
▼ Click to expandPrice has slipped below the original entry support zone of $89.59-$89.90, and the regime has shifted from calm/bullish to No Edge/bearish with broad equity weakness. The mean-reversion bounce has not materialized in the first 3 days, and the remaining path to target requires reclaiming the $89.90 resistance first. If the support zone fails to hold, the next major support is at $85.45, making the current risk/reward less favorable than at entry.
▼ Click to expandThe original thesis for holding INTC remains intact. Price is testing a critical support zone at $89.59-$89.90, which aligns with the high-probability mean-reversion entry identified at trade inception. The 4h MACD histogram is rising, and RSI is improving, signaling strengthening momentum. The reported Intel-SK Hynix HBM4E supply talks provide a fresh fundamental catalyst, reinforcing Intel's strategic position in AI and semiconductors and supporting the case for a rebound toward the $92.77-$95.35 resistance band.
The original thesis for holding INTC remains intact. Price is testing a critical support zone at $89.59-$89.90, which aligns with the high-probability mean-reversion entry identified at trade inception. The 4h MACD histogram is rising, and RSI is improving, signaling strengthening momentum. The reported Intel-SK Hynix HBM4E supply talks provide a fresh fundamental catalyst, reinforcing Intel's strategic position in AI and semiconductors and supporting the case for a rebound toward the $92.77-$95.35 resistance band.
▼ Click to expandThe exit case hinges on the risk of support failure. If price breaks below the $89.59-$89.90 zone and invalidates the stop at $86.60, the mean-reversion thesis would collapse, and the downtrend could accelerate. Additionally, broader macro weakness or a failure of the HBM4E catalyst to materialize could erode confidence in the rebound scenario.
▼ Click to expandIntraday discovery triggered reanalysis on INTC. Verdict: HOLD (0/3 EXIT). Conviction: 74.